Full Text of HB1248 095th General Assembly
HB1248 95TH GENERAL ASSEMBLY
|
|
|
95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008 HB1248
Introduced 2/15/2007, by Rep. Elizabeth Coulson SYNOPSIS AS INTRODUCED: |
|
225 ILCS 85/22 |
from Ch. 111, par. 4142 |
225 ILCS 85/22b new |
|
|
Amends the Pharmacy Practice Act of 1987. Provides that prior to dispensing a prescription, a pharmacist must present the patient or a person legally authorized to make decisions for the patient with the option of having the symptom or purpose for the medication disclosed on the prescription label, and that if the patient or person legally authorized to make decisions for the patient chooses to have the symptom or purpose for the medication disclosed on the label, the pharmacist must specify the symptom or purpose of the medication in the prescription order and the prescription label must contain that symptom or purpose.
|
| |
|
|
| FISCAL NOTE ACT MAY APPLY | |
|
|
A BILL FOR
|
|
|
|
|
HB1248 |
|
LRB095 06528 RAS 26630 b |
|
| 1 |
| AN ACT concerning regulation.
| 2 |
| Be it enacted by the People of the State of Illinois,
| 3 |
| represented in the General Assembly:
| 4 |
| Section 5. The Pharmacy Practice Act of 1987 is amended by | 5 |
| changing Section 22 and by adding Section 22b as follows:
| 6 |
| (225 ILCS 85/22) (from Ch. 111, par. 4142)
| 7 |
| (Section scheduled to be repealed on January 1, 2008)
| 8 |
| Sec. 22. Except only in the case of a drug, medicine or | 9 |
| poison
which is lawfully sold or dispensed, at retail, in the | 10 |
| original and
unbroken package of the manufacturer, packer, or | 11 |
| distributor thereof,
and which package bears the original label | 12 |
| thereon showing the name
and address of the manufacturer, | 13 |
| packer, or distributor thereof, and
the name of the drug, | 14 |
| medicine, or poison therein contained, and the
directions for | 15 |
| its use, no person shall sell or dispense, at retail,
any drug, | 16 |
| medicine, or poison, without affixing to the box, bottle,
| 17 |
| vessel, or package containing the same, a label bearing the | 18 |
| name of
the article distinctly shown, and the directions for | 19 |
| its use, with
the name and address of the pharmacy wherein the | 20 |
| same is sold or dispensed.
However, in the case of a drug, | 21 |
| medicine, or poison which is sold or
dispensed pursuant to a | 22 |
| prescription of a physician licensed to practice
medicine in | 23 |
| all of its branches, licensed dentist, licensed veterinarian,
|
|
|
|
HB1248 |
- 2 - |
LRB095 06528 RAS 26630 b |
|
| 1 |
| licensed podiatrist, or therapeutically or diagnostically | 2 |
| certified
optometrist authorized by law to prescribe drugs or | 3 |
| medicines or poisons,
the label affixed to the box, bottle, | 4 |
| vessel, or package containing the
same shall show: (a) the name | 5 |
| and address of the pharmacy
wherein the same is sold or | 6 |
| dispensed; (b) the name or initials of
the person, authorized | 7 |
| to practice pharmacy under the provisions of
this Act, selling | 8 |
| or dispensing the same, (c) the date on which such
prescription | 9 |
| was filled; (d) the name of the patient; (e) the serial
number | 10 |
| of such prescription as filed in the prescription files; (f)
| 11 |
| the last name of the practitioner who prescribed such | 12 |
| prescriptions;
(g) the directions for use thereof as contained | 13 |
| in such prescription;
and (h) the proprietary name or names or | 14 |
| the established name or
names of the drugs, the dosage and | 15 |
| quantity, except as otherwise authorized
by regulation of the | 16 |
| Department ; and (i) the symptom or purpose for which the drug | 17 |
| is being prescribed if the prescription order specifies the | 18 |
| symptom or purpose as provided for under Section 22b of this | 19 |
| Act .
The Department shall establish rules governing labeling in | 20 |
| Division II and
Division III pharmacies.
| 21 |
| (Source: P.A. 92-880, eff. 1-1-04.)
| 22 |
| (225 ILCS 85/22b new) | 23 |
| Sec. 22b. Statement of symptom or purpose on prescription | 24 |
| label.
| 25 |
| (a) The General Assembly finds that by authorizing |
|
|
|
HB1248 |
- 3 - |
LRB095 06528 RAS 26630 b |
|
| 1 |
| pharmacists to print the symptom or purpose of medications on | 2 |
| prescription labels, possible medication errors may be | 3 |
| avoided. | 4 |
| (b) Prior to dispensing a prescription, a pharmacist must | 5 |
| present the patient or a person legally authorized to make | 6 |
| decisions for the patient with the option of having the symptom | 7 |
| or purpose for the medication disclosed on the prescription | 8 |
| label. If the patient or person legally authorized to make | 9 |
| decisions for the patient chooses to have the symptom or | 10 |
| purpose for the medication disclosed on the label, the | 11 |
| pharmacist must specify the symptom or purpose of the | 12 |
| medication in the prescription order.
|
|